Genetically modified pig liver keeps man alive until human organ transplant
For the first time, a procedure using a genetically modified pig liver has been performed on a living person to bridge the gap to a human transplant.
Executive Briefing
⚡ AI SynthesisA medical team in China successfully used a genetically modified pig liver as an external bridge for a 56-year-old man with acute liver failure. This procedure, known as extracorporeal perfusion, stabilized the patient for several days until a human donor organ became available, marking a significant milestone in xenotransplantation.
Genes altered to prevent organ rejection.
Recipient suffering from chronic liver failure.
Time spent connected to external liver.
Key Takeaways
First pig liver perfusion on living person.
Six genetic modifications reduced rejection risk.
Procedure served as successful bridging therapy.
Patient successfully transitioned to human liver.
Top Entities & Concepts
Comparative Analysis
Assessment Radar
Timeline & Key Events
Tone Analysis
Positive
The text highlights a successful medical outcome and a remarkable achievement in xenotransplantation.